December 1, 2025

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Navigating 16.42% Potential Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention with its compelling growth prospects in the specialized field of rare neuroendocrine diseases. As a commercial-stage biopharmaceutical company, Rhythm is making..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring the 125% Potential Upside

Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company, has recently caught the attention of investors with its substantial potential upside of 125.05%. The company, headquartered in Redwood City, California, operates..

Verona Pharma plc (VRNA) Investor Outlook: Navigating a $9.09 Billion Biotech with a Focus on Respiratory Therapies

Verona Pharma plc (NASDAQ: VRNA), a key player in the biotechnology sector, commands the attention of investors with its specialized focus on addressing unmet medical needs in respiratory diseases. With..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a Potential 8.5% Upside in a Volatile Market

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector specializing in medical instruments and supplies, is currently navigating a challenging market landscape. With a market capitalization of $5.06..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Analyst Consensus and a Promising 7.65% Upside

Tenet Healthcare Corporation (NYSE: THC), a key player in the healthcare sector, has caught the attention of investors with its robust market presence and promising growth potential. Headquartered in Dallas,..

Krystal Biotech, Inc. (KRYS): Analyst Consensus and Growth Potential in the Biotech Sector

Krystal Biotech, Inc. (NASDAQ: KRYS) is a rising star in the biotechnology sector, with a market capitalization of $6.32 billion. This commercial-stage biotech company is making waves with its innovative..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 15% Upside Potential in the Biotech Sector

Genmab A/S (GMAB), a prominent player in the biotechnology sector, has been making waves with its robust pipeline and strategic collaborations. As a Denmark-based company, Genmab has carved out a..

Sarepta Therapeutics (SRPT) Stock Analysis: Is the Biotech Firm’s Current Valuation a Bargain?

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, has captured investor attention with its focus on RNA-targeted therapeutics and gene therapies, particularly for rare diseases like..

Telix Pharmaceuticals (TLX): Investor Outlook with a Promising 111% Upside

Telix Pharmaceuticals Limited (TLX), an innovative player in the biotechnology industry, has piqued investor interest with its promising pipeline in the field of radiopharmaceuticals. Headquartered in North Melbourne, Australia, Telix..

Moderna, Inc. (MRNA) Stock Analysis: Exploring a 43.23% Upside Potential Amid Market Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, is known for its innovative approach to mRNA medicines. With a market capitalization of $10.15 billion, the company has..

Regencell Bioscience Holdings L (RGC) Stock Analysis: A Look Into Its Volatile Journey and Healthcare Ambitions

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is an intriguing player in the healthcare sector, particularly within the niche of Traditional Chinese Medicine (TCM) targeting neurocognitive disorders. As an investor, understanding..

Revolution Medicines, Inc. (RVMD): A Promising Biotech Play with Strong Buy Ratings

Revolution Medicines, Inc. (NASDAQ: RVMD) is making substantial waves in the biotechnology sector, primarily focusing on precision oncology with a robust pipeline targeting RAS-addicted cancers. With a market capitalization of..

ICON plc (ICLR) Stock Analysis: Unveiling a 11.45% Potential Upside

ICON plc (NASDAQ: ICLR), a Dublin-based clinical research organization, is standing out in the healthcare sector with its expansive portfolio of development and commercialization services. Specializing in supporting the clinical..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Biotech Innovator with Robust Growth Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is capturing investor attention in the biotechnology sector with its innovative approach to drug delivery and strong financial performance. With a market capitalization of $8.4..

Waters Corporation (WAT) Stock Analysis: Navigating Growth in Healthcare with a 32.99% ROE

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector, continues to attract attention with its robust presence in the diagnostics and research industry. Headquartered in Milford, Massachusetts, Waters Corporation..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with 32% Revenue Growth and Strong Buy Ratings

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector with its groundbreaking medical devices designed to revolutionize organ transplant therapy. With a market capitalization of $5 billion,..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with 37% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) is a name that resonates with innovation in the healthcare sector, particularly in the niche of diagnostic and therapeutic products. With a market capitalization of..

Option Care Health, Inc. (OPCH) Stock Analysis: Healthcare Giant with a 13.5% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, particularly in medical care facilities, offers investors a compelling opportunity with a potential upside of 13.5%. The..

West Pharmaceutical Services (WST): A Healthcare Stock with a Promising 26.52% Upside

West Pharmaceutical Services, Inc. (NYSE: WST) presents itself as a compelling opportunity for investors looking to leverage growth in the healthcare sector. With a market capitalization of $19.95 billion, this..

Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Innovator with a 4.65% Potential Upside

Penumbra, Inc. (NYSE: PEN), a prominent player in the healthcare sector, continues to capture investor attention with its innovative medical devices and impressive growth metrics. Headquartered in Alameda, California, Penumbra..

Search

Funds

December 1, 2025

Search

Funds

December 1, 2025

FTSE 100

Funds